ATP1B1
MOLECULAR TARGETATPase Na+/K+ transporting subunit beta 1
ATP1B1 (ATPase Na+/K+ transporting subunit beta 1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ATP1B1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Digoxin | 2.40 | 10 |
| 2 | Ouabain | 2.30 | 9 |
| 3 | Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. | 2.08 | 7 |
| 4 | Digitoxin | 1.39 | 3 |
| 5 | Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. | 1.10 | 2 |
| 6 | Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide. | 0.69 | 1 |
About ATP1B1 as a Drug Target
ATP1B1 (ATPase Na+/K+ transporting subunit beta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented ATP1B1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ATP1B1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.